{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:06:17Z","timestamp":1792785977463,"version":"4.5.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Lester Baker Chair and the Children\u2019s Hospital of Philadelphia Research Institute","id":[{"id":"https:\/\/ror.org\/01z7r7q48","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,24]]},"DOI":"10.1093\/jbmr\/zjag078","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T11:48:50Z","timestamp":1778672930000},"page":"1041-1044","source":"Crossref","is-referenced-by-count":0,"title":["Palopegteriparatide therapy for hypoparathyroidism: targeting the PTH receptor rouses the sleeping skeleton"],"prefix":"10.1093","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0036-7809","authenticated-orcid":false,"given":"Michael A","family":"Levine","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Diabetes and The Center for Bone Health at The Children\u2019s Hospital of Philadelphia , and Department of Pediatrics at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"issue":"2","key":"2026092707514662100_ref1","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1210\/jc.2017-01471","article-title":"Recombinant human parathyroid hormone effect on health-related quality of life in adults with chronic hypoparathyroidism","volume":"103","author":"Vokes","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2026092707514662100_ref2","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1001\/jama.1996.03540080053029","article-title":"Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism","volume":"276","author":"Winer","year":"1996","journal-title":"JAMA"},{"issue":"10","key":"2026092707514662100_ref3","first-page":"3480","article-title":"A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidism","volume":"83","author":"Winer","year":"1998","journal-title":"J Clin EndocrinolMetab"},{"issue":"9","key":"2026092707514662100_ref4","doi-asserted-by":"publisher","first-page":"4214","DOI":"10.1210\/jc.2002-021736","article-title":"Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium","volume":"88","author":"Winer","year":"2003","journal-title":"J ClinEndocrinolMetab"},{"key":"2026092707514662100_ref5","doi-asserted-by":"publisher","first-page":"115977","DOI":"10.1016\/j.bone.2021.115977","article-title":"Therapy with PTH 1-34 or calcitriol and calcium in diverse etiologies of hypoparathyroidism over 27 years at a single tertiary care center","volume":"149","author":"Winer","year":"2021","journal-title":"Bone"},{"issue":"4","key":"2026092707514662100_ref6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S2213-8587(13)70106-2","article-title":"Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study","volume":"1","author":"Mannstadt","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2026092707514662100_ref7","doi-asserted-by":"publisher","first-page":"e372","DOI":"10.1210\/clinem\/dgab577","article-title":"PaTH forward: a randomized, double-blind, placebo-controlled phase 2 trial of TransCon PTH in adult hypoparathyroidism","volume":"107","author":"Khan","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026092707514662100_ref8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/jbmr.4726","article-title":"Efficacy and safety of parathyroid hormone replacement with TransCon PTH in hypoparathyroidism: 26-week results from the phase 3 PaTHway trial","volume":"38","author":"Khan","year":"2023","journal-title":"J Bone Miner Res"},{"key":"2026092707514662100_ref9","doi-asserted-by":"publisher","DOI":"10.1093\/jbmr\/zjag013","article-title":"Palopegteriparatide for adults with chronic hypoparathyroidism: skeletal dynamics through 3 yr of the phase 2 paTH forward trial","author":"Rubin","year":"2026","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2026092707514662100_ref10","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1002\/jbmr.4780","article-title":"The clinical and skeletal effects of long-term therapy of hypoparathyroidism with rhPTH(1-84)","volume":"38","author":"Agarwal","year":"2023","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2026092707514662100_ref11","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.bone.2009.09.020","article-title":"Three dimensional cancellous bone structure in hypoparathyroidism","volume":"46","author":"Rubin","year":"2010","journal-title":"Bone"},{"issue":"11","key":"2026092707514662100_ref12","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1002\/jbmr.452","article-title":"PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism","volume":"26","author":"Rubin","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2026092707514662100_ref13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/8756-3282(95)00443-2","article-title":"Bone histomorphometry in hypoparathyroid patients treated with vitamin D","volume":"18","author":"Langdahl","year":"1996","journal-title":"Bone"},{"issue":"2","key":"2026092707514662100_ref14","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00198-019-05177-2","article-title":"PTH and bone material strength in hypoparathyroidism as measured by impact microindentation","volume":"31","author":"Starr","year":"2020","journal-title":"Osteoporos Int"},{"issue":"2","key":"2026092707514662100_ref15","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/cen.13895","article-title":"Increased mortality and morbidity in patients with chronic hypoparathyroidism: a population-based study","volume":"90","author":"Vadiveloo","year":"2019","journal-title":"Clin Endocrinol"},{"issue":"11","key":"2026092707514662100_ref16","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1002\/jbmr.2273","article-title":"Postsurgical hypoparathyroidism--risk of fractures, psychiatric diseases, cancer, cataract, and infections","volume":"29","author":"Underbjerg","year":"2014","journal-title":"J Bone Miner Res"},{"issue":"9","key":"2026092707514662100_ref17","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1002\/jbmr.2501","article-title":"The epidemiology of nonsurgical hypoparathyroidism in Denmark: a Nationwide case finding study","volume":"30","author":"Underbjerg","year":"2015","journal-title":"J Bone Miner Res"},{"issue":"7","key":"2026092707514662100_ref18","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1093\/jbmr\/zjaf061","article-title":"Increased risk of vertebral fractures and reduced risk of femur fractures in patients with chronic hypoparathyroidism: a nationwide cohort study in Sweden","volume":"40","author":"Bjornsdottir","year":"2025","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2026092707514662100_ref19","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1210\/endrev\/bnab005","article-title":"Physiological and pharmacological roles of PTH and PTHrP in Bone using their shared receptor, PTH1R","volume":"42","author":"Martin","year":"2021","journal-title":"Endocr Rev"},{"issue":"2","key":"2026092707514662100_ref20","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/bcp.13455","article-title":"Optimal dosing and delivery of parathyroid hormone and its analogues for osteoporosis and hypoparathyroidism - translating the pharmacology","volume":"84","author":"Tay","year":"2018","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"2026092707514662100_ref21","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1002\/jbmr.4016","article-title":"A randomized double-blind placebo-controlled first-In-human phase 1 trial of TransCon PTH in healthy adults","volume":"35","author":"Karpf","year":"2020","journal-title":"J Bone Miner Res"},{"issue":"11","key":"2026092707514662100_ref22","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1093\/jbmr\/zjaf118","article-title":"Advances in parathyroid hormone-based medicines","volume":"40","author":"Bonnet","year":"2025","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2026092707514662100_ref23","doi-asserted-by":"publisher","first-page":"bvad043","DOI":"10.1210\/jendso\/bvad043","article-title":"Long-term safety and efficacy of recombinant human parathyroid hormone (1-84) in adults with chronic hypoparathyroidism","volume":"7","author":"Watts","year":"2023","journal-title":"J Endocr Soc"},{"issue":"6","key":"2026092707514662100_ref24","doi-asserted-by":"crossref","DOI":"10.1530\/EC-24-0464","article-title":"Phase 1 clinical trial of eneboparatide, a novel PTH receptor 1 agonist","volume":"14","author":"Ovize","year":"2025","journal-title":"Endocr Connect"},{"issue":"3","key":"2026092707514662100_ref25","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00198-018-04819-1","article-title":"Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: results from ACTIVE","volume":"30","author":"Eastell","year":"2019","journal-title":"Osteoporos Int"},{"issue":"10","key":"2026092707514662100_ref26","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1002\/jbmr.470","article-title":"The effect of adding PTH(1-84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study","volume":"26","author":"Sikjaer","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2026092707514662100_ref27","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1210\/jc.2011-1908","article-title":"Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism","volume":"97","author":"Winer","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026092707514662100_ref28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11914-025-00905-6","article-title":"PTH substitution therapy for chronic hypoparathyroidism: PTH 1-84 and Palopegteriparatide","volume":"23","author":"Palermo","year":"2025","journal-title":"Curr Osteoporos Rep"},{"issue":"7","key":"2026092707514662100_ref29","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1002\/jbmr.4566","article-title":"Safety and efficacy of PTH 1-34 and 1-84 therapy in chronic hypoparathyroidism: a meta-analysis of prospective trials","volume":"37","author":"Puliani","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2026092707514662100_ref30","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1007\/s12325-024-02843-8","article-title":"Palopegteriparatide treatment improves renal function in adults with chronic hypoparathyroidism: 1-year results from the phase 3 PaTHway trial","volume":"41","author":"Rejnmark","year":"2024","journal-title":"Adv Ther"},{"issue":"1","key":"2026092707514662100_ref31","doi-asserted-by":"publisher","first-page":"4487","DOI":"10.1038\/s41467-025-59665-7","article-title":"Prolonging parathyroid hormone analog action in vitro and in vivo through peptide lipidation","volume":"16","author":"H\u00f6ppner","year":"2025","journal-title":"Nat Commun"},{"issue":"6","key":"2026092707514662100_ref32","doi-asserted-by":"publisher","first-page":"ziae045","DOI":"10.1093\/jbmrpl\/ziae045","article-title":"Preclinical development of EXT608, an investigational parathyroid hormone derivative with extended half-life for the treatment of hypoparathyroidism","volume":"8","author":"Hall","year":"2024","journal-title":"JBMR Plus"},{"key":"2026092707514662100_ref33","author":"Discovery PaNEoGD","year":"2026"},{"key":"2026092707514662100_ref34","doi-asserted-by":"publisher","first-page":"102345","DOI":"10.1016\/j.molmet.2026.102345","article-title":"Discovery and characterization of canvuparatide, a once-weekly parathyroid hormone analog for the treatment of hypoparathyroidism","volume":"107","author":"Zhang","year":"2026","journal-title":"Mol Metab"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbmr\/advance-article-pdf\/doi\/10.1093\/jbmr\/zjag078\/68293418\/zjag078.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/41\/10\/1041\/68293418\/zjag078.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/41\/10\/1041\/68293418\/zjag078.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:51:55Z","timestamp":1790509915000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/41\/10\/1041\/8678956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":34,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,5,15]]},"published-print":{"date-parts":[[2026,9,24]]}},"URL":"https:\/\/doi.org\/10.1093\/jbmr\/zjag078","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,5,15]]}}}